These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1012449)

  • 1. Dopamine-beta-hydroxylase activity in serum and cerebrospinal fluid in neuropsychiatric diseases.
    Okada T; Ohta T; Shinoda T; Kato T; Ikuta K
    Neuropsychobiology; 1976; 2(2-3):139-44. PubMed ID: 1012449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
    Meltzer HY; Tong C; Luchins DJ
    Biol Psychiatry; 1984 Oct; 19(10):1395-402. PubMed ID: 6335052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
    Sternberg DE; VanKammen DP; Lerner P; Bunney WE
    Science; 1982 Jun; 216(4553):1423-5. PubMed ID: 6124036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum dopamine-beta-hydroxylase activity: clinical applications in child psychiatry.
    Young JG; Kyprie RM; Ross NT; Cohen DJ
    J Autism Dev Disord; 1980 Mar; 10(1):1-14. PubMed ID: 6085951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF dopamine beta-hydroxylase in schizophrenia.
    Sternberg DE; van Kammen DP; Lerner P; Ballenger JC; Marder SR; Post RM; Bunney WE
    Arch Gen Psychiatry; 1983 Jul; 40(7):743-7. PubMed ID: 6134515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients.
    Lerner P; Goodwin FK; van Kammen DP; Post RM; Major LF; Ballenger JC; Lovenberg W
    Biol Psychiatry; 1978 Dec; 13(6):685-94. PubMed ID: 737256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients.
    Meltzer HY; Cho HW; Carroll BJ; Russo P
    Arch Gen Psychiatry; 1976 May; 33(5):585-91. PubMed ID: 1267575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-beta-hydroxylase in cerebrospinal fluid and plasma: effects of alpha-adrenergic agents.
    Lerner P; Dendel PS; Major LF
    Brain Res; 1980 May; 189(1):183-91. PubMed ID: 7363084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in serum dopamine beta-hydroxylase in normal subjects and chronic alcoholics.
    Sellers EM; Cooper SD; Roy ML
    Can J Physiol Pharmacol; 1978 Oct; 56(5):806-11. PubMed ID: 568508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma dopamine beta-hydroxylase activity in a North Swedish isolate with a high frequency of schizophrenia.
    Ross SB; Böök JA; Wetterberg L
    Clin Genet; 1981 May; 19(5):415-7. PubMed ID: 7296932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients.
    Yu PH; O'Sullivan KS; Keegan D; Boulton AA
    Psychiatry Res; 1980 Oct; 3(2):205-10. PubMed ID: 6947313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation.
    Cubells JF; van Kammen DP; Kelley ME; Anderson GM; O'Connor DT; Price LH; Malison R; Rao PA; Kobayashi K; Nagatsu T; Gelernter J
    Hum Genet; 1998 May; 102(5):533-40. PubMed ID: 9654201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in plasma dopamine-beta-hydroxylase activity in patients with acute subarachnoid hemorrhage (author's transl)].
    Abe N; Tominaga S; Ohta H; Kawakami H; Tagawa K; Suzuki T; Kutsuzawa T
    No To Shinkei; 1979 Aug; 31(8):771-7. PubMed ID: 574016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients.
    Miyata S; Nagata H; Yamao S; Nakamura S; Kameyama M
    J Neurol Sci; 1984 Mar; 63(3):403-9. PubMed ID: 6726279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of plasma dopamine beta-hydroxylase activity in essential and secondary hypertension.
    Iseki F; Kuchii M; Nishio I; Masuyama Y
    Jpn Heart J; 1979 May; 20(3):307-20. PubMed ID: 572440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
    Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O
    Encephale; 1981; 7(1):95-103. PubMed ID: 7227288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.